2023-10-01 2024-09-30 false Capium Accounts Production 1.1 13597716 2023-10-01 2024-09-30 13597716 bus:FullAccounts 2023-10-01 2024-09-30 13597716 bus:FRS102 2023-10-01 2024-09-30 13597716 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 13597716 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 13597716 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 13597716 2023-10-01 2024-09-30 13597716 2024-09-30 13597716 bus:RegisteredOffice 2023-10-01 2024-09-30 13597716 core:WithinOneYear 2024-09-30 13597716 core:AfterOneYear 2024-09-30 13597716 1 2023-10-01 2024-09-30 13597716 bus:Director1 2023-10-01 2024-09-30 13597716 bus:Director1 2024-09-30 13597716 bus:Director1 2022-10-01 2023-09-30 13597716 2022-10-01 13597716 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 13597716 2022-10-01 2023-09-30 13597716 2023-09-30 13597716 core:WithinOneYear 2023-09-30 13597716 core:AfterOneYear 2023-09-30 13597716 bus:EntityAccountantsOrAuditors 2022-10-01 2023-09-30 13597716 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 13597716 bus:OrdinaryShareClass1 2024-09-30 13597716 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 13597716 bus:OrdinaryShareClass1 2023-09-30 13597716 core:FurnitureFittings 2023-10-01 2024-09-30 13597716 core:FurnitureFittings 2024-09-30 13597716 core:FurnitureFittings 2023-09-30 13597716 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 13597716 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 13597716 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 13597716 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 13597716 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 13597716 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 13597716 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 13597716 core:Non-currentFinancialInstruments 2024-09-30 13597716 core:Non-currentFinancialInstruments 2023-09-30 13597716 core:ShareCapital 2024-09-30 13597716 core:ShareCapital 2023-09-30 13597716 core:RetainedEarningsAccumulatedLosses 2024-09-30 13597716 core:RetainedEarningsAccumulatedLosses 2023-09-30 13597716 dpl:Item1 2023-10-01 13597716 dpl:Item1 2024-09-30 13597716 dpl:Item1 2022-10-01 13597716 dpl:Item1 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13597716
England and Wales

 

 

 


Filleted Accounts


for the year ended 30 September 2024

for

DANIELLE JAMES SKIN CLINIC (NW) LTD

 
 		 Notes
 		 2024
£		   2023
£
Fixed assets      
Tangible fixed assets 3 20,614    27,485 
20,614    27,485 
Current assets      
Cash at bank and in hand 4,023    101 
Creditors: amount falling due within one year 4 (7,339)   (7,991)
Net current assets (3,316)   (7,890)
 
Total assets less current liabilities 17,298    19,595 
Creditors: amount falling due after more than one year 5 (50,000)   (50,000)
Net assets (32,702)   (30,405)
 

Capital and reserves 		     
Called up share capital 6 100    100 
Profit and loss account (32,802)   (30,505)
Shareholders' funds (32,702)   (30,405)
 


For the year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 30 September 2025 and were signed by:


-------------------------------
Danielle James
Director
1
General Information
Danielle James Skin Clinic (NW) Ltd is a private company, limited by shares, registered in England and Wales, registration number 13597716, registration address 9a Woolton Street, Liverpool, Merseyside, L25 5NH.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 October 2023 48,863    48,863 
Additions -    - 
Disposals -    - 
At 30 September 2024 48,863    48,863 
Depreciation
At 01 October 2023 21,378    21,378 
Charge for year 6,871    6,871 
On disposals -    - 
At 30 September 2024 28,249    28,249 
Net book values
Closing balance as at 30 September 2024 20,614    20,614 
Opening balance as at 01 October 2023 27,485    27,485 


4.

Creditors: amount falling due within one year

2024
£		   2023
£
Trade Creditors 548    150 
Directors' Current Accounts 6,791    7,841 
7,339    7,991 

5.

Creditors: amount falling due after more than one year

2024
£		   2023
£
Other Creditors 50,000    50,000 
50,000    50,000 

6.

Share Capital

Allotted, called up and fully paid
2024
£		   2023
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

2